Pharmaceuticals & Life Sciences Articles & Blogs

The Bletchley Declaration - what does it mean for AI in Pharma?

Thursday, 16 November 2023

Artificial Intelligence (AI) is the buzz phrase of the year in the UK and beyond. After the UK held an AI Safety Summit in November, the countries participating signed up to the Bletchley Declaration. But what does it mean for pharma?

The Bletchley Declaration - what does it mean for AI in Pharma?

Articles & Blogs Pharma & Life Sciences

The start of the overhaul - low-risk UK clinical trial approvals made quicker

Thursday, 16 November 2023

The MHRA's guidance on clinical trial applications was updated in October. The guidance refers to a new notification scheme, which was the subject of an MHRA press release dated 12 October 2023.

The start of the overhaul - low-risk UK clinical trial approvals made quicker

Articles & Blogs Pharma & Life Sciences

Marketing authorisation - International Recognition Procedure confirmed

Thursday, 16 November 2023

From next year, organisations holding marketing authorisations (MA) in an approved list of countries can benefit from a new 'International Recognition Procedure' to gain access to the UK market.

Marketing authorisation - International Recognition Procedure confirmed

Articles & Blogs Pharma & Life Sciences

The future of expedited access to innovative medical devices - IDAP clearing the path for eight lucky applicants

Tuesday, 17 October 2023

How do medical devices get on the market quickly? There are lots of (usually long) answers to this question, but one significant new route will be via the Innovative Devices Access Pathway (IDAP).

The future of expedited access to innovative medical devices - IDAP clearing the path for eight lucky applicants

Articles & Blogs Pharma & Life Sciences

The lawyer's role in the future of UK clinical research - What would Lord O'Shaughnessy say?

Friday, 22 September 2023

Following last year's review from Lord O'Shaughnessy on the UK commercial clinical trial landscape, all of us (including lawyers) need to reflect on how to solve the issues flagged in the report.

The lawyer's role in the future of UK clinical research - What would Lord O'Shaughnessy say?

Articles & Blogs Pharma & Life Sciences

Planning consent granted for Europe's most technologically advanced life sciences building at Canary Wharf

Thursday, 21 September 2023

Canary Wharf is rapidly developing to accommodate the Life Sciences Sector - planning consent granted by Tower Hamlets Council for a unique 23-strorey vertical campus encourages an ecosystem within this industry to flourish.

Planning consent granted for Europe's most technologically advanced life sciences building at Canary Wharf

Articles & Blogs Pharma & Life Sciences

Stevenage approves one of Europe's biggest life sciences campuses

Wednesday, 20 September 2023

Stevenage Council has approved one of Europe’s largest Life Science campuses - £900m life science campus with 1.6 million square foot of lab, office and Good Manufacturing Practices (GMP) facilities, and creating 5,000 jobs.

Stevenage approves one of Europe's biggest life sciences campuses

Articles & Blogs Pharma & Life Sciences

How to Navigate the UK's Medtech Sector - Key Developments to Watch

Tuesday, 15 August 2023

As the UK medtech strategy acknowledges multiple times, the sector is complex. Here are a few key developments to be aware of.

How to Navigate the UK's Medtech Sector - Key Developments to Watch

Articles & Blogs Pharma & Life Sciences

Crick Director Warns UK Has to Join EU Horizon Programme

Monday, 07 August 2023

The UK must be part of the EU's Horizon programme if it wants to achieve its ambition of being a 'science superpower'. That is the warning of Sir Paul Nurse, director at the Francis Crick Institute.

Crick Director Warns UK Has to Join EU Horizon Programme

Articles & Blogs Pharma & Life Sciences

The UK's New Medtech Strategy, Explained

Monday, 31 July 2023

Medical device businesses face a whirlwind of change covering the EU and UK. Commercialising medical devices in these regions means navigating multifaceted challenges, legal and beyond. Here's our overview of what you need to know.

The UK's New Medtech Strategy, Explained

Articles & Blogs Pharma & Life Sciences

Pharmaceuticals in the Environment Group Formed

Tuesday, 18 July 2023

The Pharmaceuticals in the Environment Group (the Group) is a cross-government platform that has been created to acknowledge potential contributors to pharmaceuticals entering the environment, and discuss the unintended consequences.

Pharmaceuticals in the Environment Group Formed

Articles & Blogs Pharma & Life Sciences

Regulatory Shortages and Delays - Navigating the MHRA's Post-Brexit Transition

Tuesday, 18 July 2023

The regulatory shortages and delays faced by the Medicines and Healthcare products Regulatory Agency (MHRA) in the aftermath of Brexit have raised concerns in the pharmaceutical industry regarding the timely launch of products in the UK market.

Regulatory Shortages and Delays - Navigating the MHRA's Post-Brexit Transition

Articles & Blogs Pharma & Life Sciences

London Tech Week - Key Takeaways for the MedTech Industry

Tuesday, 27 June 2023

London Tech Week 2023 recently took place in the UK's capital, attracting many in the field of MedTech to discuss their challenges.

London Tech Week - Key Takeaways for the MedTech Industry

Articles & Blogs Pharma & Life Sciences

Government Boosts UK Life Sciences with £650m 'Life Sci' Package

Friday, 05 May 2023

The Government has given UK life sciences a boost with a £650 million multi-faceted package of 'Life Sci for Growth' measures - recognising the importance of an industry worth over £94 billion and employing more than 280,000 in the UK.

Government Boosts UK Life Sciences with £650m 'Life Sci' Package

Articles & Blogs Pharma & Life Sciences

Parliament Debate Calls for New Approach to VPAS to Protect UK Life Sciences

Monday, 22 May 2023

A Parliament debate has called for a new approach to the Voluntary Pricing and Access Scheme (VPAS) if the UK is to be seen as an attractive place for life sciences.

Parliament Debate Calls for New Approach to VPAS to Protect UK Life Sciences

Pharma & Life Sciences

Share this page: